Buscar

Mostrando ítems 1-10 de 205

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study

Folschweiller, Nicolas; Teixeira, Julio; Joshi, Smita; Goldani, Luciano Z.; Supparatpinyo, Khuanchai; Basu, Partha; Chotpitayasunondh, Tawee; Chetchotisakd, Ploenchan; Ruxrungtham, Kiat; Roteli-Martins, Cecilia; Grinsztejn, Beatriz; Quintana, Silvana Maria; Kumarasamy, Nagalingeswaran; Poongulali, Selvamuthu; Kulkarni, Vinay; Lin, Lan; Datta, Sanjoy K.; Descamps, Dominique; Dodet, Monique; Dubin, Gary; Friel, Damien; Hezareh, Marjan; Karkada, Naveen; Meric Camilleri, Dorothee; Poncelet, Sylviane; Salaun, Bruno; Tavares-da-Silva, Fernanda; Thomas-Jooris, Florence; Struyf, Frank (Elsevier, 2020)

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age

Moreira Junior, Edson Duarte; Giuliano, A R; Hoon, J de; Iversen, O-E; Joura, E A; Restrepo, J; Van Damme, P; Vandermeulen, C; Ellison, M C; Krick, A; Shields, C; Heiles, B; Luxembourg, Alain (Taylor & Francis, 2018)

Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation

Szarewski, A; Skinner, SR; Garland, SM; Romanowski, B; Schwarz, TF; Apter, D; Chow, SN; Paavonen, J; Del Rosario-Raymundo, MR; Teixeira, JC; De Carvalho, NS; Castro-Sanchez, M; Castellsague, X; Poppe, WAJ; De Sutter, P; Huh, W; Chatterjee, A; Tjalma, WA; Ackerman, RT; Martens, M; Papp, KA; Bajo-Arenas, J; Harper, DM; Torne, A; David, MP; Struyf, F; Lehtinen, M; Dubin, G (Oxford Univ Press IncCaryEUA, 2013)

Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine up to 8.4 years of follow-up

Roteli-Martins, CM; Naud, P; De Borba, P; Teixeira, JC; De Carvalho, NS; Zahaf, T; Sanchez, N; Geeraerts, B; Descamps, D (Landes BioscienceAustinEUA, 2012)

Randomized trial of HPV4 vaccine assessing the response to HPV4 vaccine in two schedules among Peruvian female sex workers

Autor desconocido (Elsevier, 2012)

Two hundred female sex workers (FSWs) in Lima, Peru were randomized to receive HPV4 vaccine in the standard (0, 2, 6 months) or a modified schedule (0, 3, 6 months). One hundred and eighty four (92%) participants completed ...

Opportunity for catch-up HPV vaccination in young women after first delivery

RAMA, Cristina Helena; VILLA, Luisa L.; PAGLIUSI, Sonia; ANDREOLI, Maria A.; COSTA, Maria C.; THOMANN, Patricia; ALVES, Venancio A. F.; LONGATTO-FILHO, Adhemar; ELUF-NETO, Jose (B M J PUBLISHING GROUP, 2010)

Background Early age at first delivery has been identified as a risk factor for high-risk HPV-type infection and cervical cancer development. Methods A cross-sectional study was carried out in a large public maternity ...

Antibody persistence and evidence of immune memory at 5years following administration of the 9-valent HPV vaccine

Guevara, Ana; Cabello, Robinson; Woelber, Linn; Moreira Junior, Edson Duarte; Joura, Elmar; Reich, Olaf; Shields, Christine; Ellison, Misoo C; Joshi, Amita; Luxembourg, Alain (Elsevier, 2018)

Seroprevalence of Human Papillomavirus 6, 11, 16, and 18 in Young Primiparous Women in Sao Paulo, Brazil

RAMA, Cristina Helena; VILLA, Luisa Lina; PAGLIUSI, Sonia; ANDREOLI, Maria Antonieta Avilla; COSTA, Maria Cecilia; THOMANN, Patricia; LONGATTO-FILHO, Adhemar; ELUF-NETO, Jose (LIPPINCOTT WILLIAMS & WILKINS, 2010)

Introduction: Data on epidemiology of HPV infection are needed for the development of human papillomavirus (HPV) vaccine recommendations, especially in countries where HPV vaccination is not yet included in public vaccination ...

Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil

Nicol, A. F.; Grinsztein, B.; Friedman, R. K.; Veloso, V. G.; Cunha, C. B.; Georg, I.; Pilotto, J. H.; Moreira, R. I; Castro, C. A. V.; Silver, B.; Viscidi, R. P. (Elsevier, 2015)

Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials

Wacholder, Sholom; Chen, Bingshu Eric; Wilcox, Allen; Macones, George; González, Paula; Befano, Brian; Hildesheim, Allan; Rodríguez, Ana Cecilia; Solomon, Diane; Herrero, Rolando; Schiffman, Mark (BMJ. 2010 Mar 2;340:c712. doi: 10.1136/bmj.c712, 2010-03)

Objective To assess whether vaccination against human papillomavirus (HPV) increases the risk of miscarriage. Design Pooled analysis of two multicentre, phase three masked randomised controlled trials Setting Multicentre ...

1
2
3
4
. . .
21